Exploring vasomotor mechanisms using new PKG inhibitors
使用新型 PKG 抑制剂探索血管舒缩机制
基本信息
- 批准号:6620860
- 负责人:
- 金额:$ 37.88万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2002
- 资助国家:美国
- 起止时间:2002-01-01 至 2005-12-31
- 项目状态:已结题
- 来源:
- 关键词:Escherichia coli SDS polyacrylamide gel electrophoresis Sf9 cell line biological signal transduction cGMP dependent protein kinase calcium channel chemical kinetics combinatorial chemistry confocal scanning microscopy enzyme inhibitors enzyme mechanism fluorescent dye /probe intracellular transport membrane permeability membrane potentials peptide chemical synthesis peptide library potassium channel radiotracer tissue /cell culture vascular endothelium vascular smooth muscle vasoconstriction voltage /patch clamp western blottings
项目摘要
DESCRIPTION (provided by applicant): Cyclic GMP-dependent protein kinase (PKG)
plays a central role in the regulation of vascular smooth muscle tone.
Activation of PKG leads to alterations in intracellular Ca2+, which in turn,
effects multiple cellular signaling pathways. However, progress in
understanding the specific functional roles of PKG in vascular smooth muscle
has been hampered by the lack of specific PKG inhibitors. We have developed
novel, cell-permeable PKG specific peptide inhibitors with unprecedented
potency and kinase specificity by fusion of peptides derived from combinatorial
libraries with membrane translocation signal (MTS) peptides. These fusion
peptides result in an extraordinary synergism with respect to PKG inhibition.
In the proposed experiments, these PKG selective inhibitors will be further
developed, refined and used to study specific functional roles of PKG in
vascular smooth muscle. Specific Aim 1 will develop novel peptide library
design strategies based on binding- and competition libraries. This approach
should lead to new and mole potent PKG inhibitors than are currently available.
Specific Aim 2 will explore variations of the MTS sequences with respect to
their use for intracellular delivery and their ability to synergize with the
library derived peptide inhibitors. Specific Aim 3 will determine the
contributions of PKG in the regulation of vascular tone in intact resistance
arteries by measuring the effects of PKG inhibitors on arterial diameter as
well as ion channel activity in single vascular smooth muscle cells. To pursue
the aims of this proposal, a multi-faceted approach will be used, including
state-of-the-art techniques to: 1) screen and synthesize selective PKG
inhibitor peptides using combinatorial library approaches, 2) deliver peptide
inhibitors using membrane translocation peptide sequences and monitor the
intracellular accumulation of these compounds using kinase activity assays,
fluorescence spectroscopy and confocal microscopy, and 3) assess the efficacy
of the PKG inhibitors using functional assays of ion channel activity (patch
clamp) and vascular contractility (myography). The studies outlined above will
provide new, selective, and potent inhibitors of PKG which will be useful in
revealing the fundamental physiological roles of PKG in regulation of arterial
tone. The application of the inhibitors that emerge from these studies will not
only demonstrate the essential role of PKG in regulation of vascular tone in
resistance arteries, but also significantly advance the field of protein kinase
signaling in general. This work may also suggest novel targets for therapeutic
interventions in vascular diseases such as hypertension and septic shock.
描述(由申请人提供):环gmp依赖性蛋白激酶(PKG)
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
WOLFGANG R DOSTMANN其他文献
WOLFGANG R DOSTMANN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('WOLFGANG R DOSTMANN', 18)}}的其他基金
Exploring vasomotor mechanisms using new PKG inhibitors
使用新型 PKG 抑制剂探索血管舒缩机制
- 批准号:
6422573 - 财政年份:2002
- 资助金额:
$ 37.88万 - 项目类别:
Exploring Vasomotor Mechanisms using New PKG Inhibitors and cGMP Biosensors
使用新型 PKG 抑制剂和 cGMP 生物传感器探索血管舒缩机制
- 批准号:
8038300 - 财政年份:2002
- 资助金额:
$ 37.88万 - 项目类别:
Exploring vasomotor mechanisms using new PKG inhibitors
使用新型 PKG 抑制剂探索血管舒缩机制
- 批准号:
6831678 - 财政年份:2002
- 资助金额:
$ 37.88万 - 项目类别:
Exploring Vasomotor Mechanisms using New PKG Inhibitors and cGMP Biosensors
使用新型 PKG 抑制剂和 cGMP 生物传感器探索血管舒缩机制
- 批准号:
7591107 - 财政年份:2002
- 资助金额:
$ 37.88万 - 项目类别:
Exploring Vasomotor Mechanisms using New PKG Inhibitors and cGMP Biosensors
使用新型 PKG 抑制剂和 cGMP 生物传感器探索血管舒缩机制
- 批准号:
7462711 - 财政年份:2002
- 资助金额:
$ 37.88万 - 项目类别:
Exploring vasomotor mechanisms using new PKG inhibitors
使用新型 PKG 抑制剂探索血管舒缩机制
- 批准号:
6688276 - 财政年份:2002
- 资助金额:
$ 37.88万 - 项目类别:
Exploring Vasomotor Mechanisms using New PKG Inhibitors and cGMP Biosensors
使用新型 PKG 抑制剂和 cGMP 生物传感器探索血管舒缩机制
- 批准号:
8247788 - 财政年份:2002
- 资助金额:
$ 37.88万 - 项目类别:
Exploring Vasomotor Mechanisms using New PKG Inhibitors and cGMP Biosensors
使用新型 PKG 抑制剂和 cGMP 生物传感器探索血管舒缩机制
- 批准号:
7798496 - 财政年份:2002
- 资助金额:
$ 37.88万 - 项目类别:














{{item.name}}会员




